AT353793B - Verfahren zur herstellung von neuen tetrahydro- isochinolinderivaten in form der reinen stereo- isomeren und ihrer gemische und ihren salzen - Google Patents
Verfahren zur herstellung von neuen tetrahydro- isochinolinderivaten in form der reinen stereo- isomeren und ihrer gemische und ihren salzenInfo
- Publication number
- AT353793B AT353793B AT717378A AT717378A AT353793B AT 353793 B AT353793 B AT 353793B AT 717378 A AT717378 A AT 717378A AT 717378 A AT717378 A AT 717378A AT 353793 B AT353793 B AT 353793B
- Authority
- AT
- Austria
- Prior art keywords
- isomers
- mixtures
- salts
- producing new
- pure stereo
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 150000003526 tetrahydroisoquinolines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB33283/75A GB1504424A (en) | 1975-08-09 | 1975-08-09 | Isoquinoline-derived aminoethers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA717378A ATA717378A (de) | 1979-05-15 |
| AT353793B true AT353793B (de) | 1979-12-10 |
Family
ID=10350917
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT586876A AT354448B (de) | 1975-08-09 | 1976-08-06 | Verfahren zur herstellung von neuen tetrahydro- isochinolinderivaten in form der reinen stereo- isomeren und ihrer gemische und ihren salzen |
| AT717378A AT353793B (de) | 1975-08-09 | 1978-10-05 | Verfahren zur herstellung von neuen tetrahydro- isochinolinderivaten in form der reinen stereo- isomeren und ihrer gemische und ihren salzen |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT586876A AT354448B (de) | 1975-08-09 | 1976-08-06 | Verfahren zur herstellung von neuen tetrahydro- isochinolinderivaten in form der reinen stereo- isomeren und ihrer gemische und ihren salzen |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4113869A (de) |
| JP (1) | JPS5223083A (de) |
| AT (2) | AT354448B (de) |
| AU (1) | AU498422B2 (de) |
| BE (1) | BE844783A (de) |
| CA (1) | CA1076119A (de) |
| CH (2) | CH622780A5 (de) |
| DE (1) | DE2635276A1 (de) |
| DK (1) | DK357976A (de) |
| ES (6) | ES450550A1 (de) |
| FR (1) | FR2320755A1 (de) |
| GB (1) | GB1504424A (de) |
| HU (1) | HU173560B (de) |
| IE (1) | IE43506B1 (de) |
| IL (1) | IL50176A (de) |
| NL (1) | NL7608856A (de) |
| NZ (1) | NZ181619A (de) |
| SE (1) | SE7608641L (de) |
| ZA (1) | ZA764555B (de) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2711655A1 (de) * | 1977-03-17 | 1978-09-21 | Basf Ag | Pyridinyl-aminoalkylaether |
| US4340600A (en) | 1980-05-22 | 1982-07-20 | Smithkline Corporation | Renal dilating methods and compositions using 4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines |
| US4766131A (en) * | 1980-10-17 | 1988-08-23 | Pennwalt Corporation | 2-amino (or hydroxy) phenethyl-1,2,3,4-tetrahydroisoquinolines as analgesics |
| US4551474A (en) * | 1981-02-19 | 1985-11-05 | Hoechst-Roussel Pharmaceuticals Incorporated | Methods of alleviating convulsions and pain employing 4-aryloxy-1,2,3,4 tetrahydroisoquinolines |
| US4477670A (en) * | 1981-02-19 | 1984-10-16 | Hoechst-Roussel Pharmaceuticals Inc. | 4-Aryloxy-1,2,3,4-tetrahydroisoquinolines |
| US4375471A (en) * | 1981-02-19 | 1983-03-01 | Hoechst-Roussel Pharmaceuticals Inc. | 4-Aryloxy-1,2,3,4-tetrahydroisoquinolines |
| US6562837B1 (en) * | 1998-10-21 | 2003-05-13 | Korea Institute Of Science & Technology | Use of tetrahydroisoquinoline compounds for the treatment of septicemia |
| AU784280B2 (en) * | 1999-11-03 | 2006-03-02 | Albany Molecular Research, Inc. | 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| DK1246806T3 (da) * | 1999-11-03 | 2008-06-16 | Amr Technology Inc | Aryl- og heteroarylsubstituerede tetrahydroisoquinoliner og anvendelse deraf til blokering af genoptagelse af norepinefrin, dopsmin og serotonin |
| US7163949B1 (en) | 1999-11-03 | 2007-01-16 | Amr Technology, Inc. | 4-phenyl substituted tetrahydroisoquinolines and use thereof |
| EP1113007A1 (de) * | 1999-12-24 | 2001-07-04 | Pfizer Inc. | Tetrahydroisochinolin-Verbindungen zur Verwendung als Östrogen-Agonisten/-Antagonisten |
| WO2002004455A2 (en) | 2000-07-11 | 2002-01-17 | Albany Molecular Research, Inc | 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| US7314937B2 (en) * | 2002-03-21 | 2008-01-01 | Eli Lilly And Company | Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses |
| KR101389246B1 (ko) | 2004-07-15 | 2014-04-24 | 브리스톨-마이어스스퀴브컴파니 | 아릴- 및 헤테로아릴-치환된 테트라히드로이소퀴놀린, 및 이것의 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도 |
| US20060111385A1 (en) * | 2004-11-22 | 2006-05-25 | Molino Bruce F | Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| US20060111394A1 (en) * | 2004-11-22 | 2006-05-25 | Molino Bruce F | Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| US20060111393A1 (en) * | 2004-11-22 | 2006-05-25 | Molino Bruce F | 4-Phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| CA2592353A1 (en) * | 2004-12-17 | 2006-06-22 | Janssen Pharmaceutica, N.V. | Tetrahydroisoquinoline compounds for treatment of cns disorders |
| AU2006259257A1 (en) * | 2005-06-17 | 2006-12-28 | Janssen Pharmaceutica N.V. | Hexahydro-pyrrolo-isoquinoline compounds for the treatment of CNS disorders |
| CA2612409A1 (en) | 2005-06-17 | 2006-12-28 | Janssen Pharmaceutica N.V. | Naphthyridine compounds |
| NZ565111A (en) * | 2005-07-15 | 2011-10-28 | Amr Technology Inc | Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| WO2008144305A1 (en) * | 2007-05-18 | 2008-11-27 | Janssen Pharmaceutica N.V. | Diaryl-substituted tetrahydroisoquinolines as histamine h3 receptor and serotonin transporter modulators |
| US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| AR071997A1 (es) * | 2008-06-04 | 2010-07-28 | Bristol Myers Squibb Co | Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina |
| JP5645840B2 (ja) | 2008-12-02 | 2014-12-24 | 株式会社Ｗａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｊａｐａｎ | リン原子修飾核酸の合成方法 |
| AU2010247763B2 (en) | 2009-05-12 | 2015-12-24 | Albany Molecular Research, Inc. | 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof |
| ES2528404T3 (es) | 2009-05-12 | 2015-02-10 | Bristol-Myers Squibb Company | Formas cristalinas de (S)-7-([1,2,4]triazol[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina y sus usos |
| ES2446971T3 (es) | 2009-05-12 | 2014-03-11 | Albany Molecular Research, Inc. | Tetrahidroisoquinolinas sustituidas con arilo, heteroarilo, y heterociclo y su uso |
| EP2451461A4 (de) | 2009-07-06 | 2013-05-29 | Ontorii Inc | Neuartige nukleinsäure-prodrugs und verwendungsverfahren dafür |
| US10428019B2 (en) * | 2010-09-24 | 2019-10-01 | Wave Life Sciences Ltd. | Chiral auxiliaries |
| WO2013012758A1 (en) | 2011-07-19 | 2013-01-24 | Ontorii, Inc. | Methods for the synthesis of functionalized nucleic acids |
| SG11201500243WA (en) | 2012-07-13 | 2015-04-29 | Shin Nippon Biomedical Lab Ltd | Chiral nucleic acid adjuvant |
| SG11201500232UA (en) | 2012-07-13 | 2015-04-29 | Wave Life Sciences Pte Ltd | Chiral control |
| RU2693381C2 (ru) | 2012-07-13 | 2019-07-02 | Уэйв Лайф Сайенсес Лтд. | Асимметричная вспомогательная группа |
| JPWO2015108047A1 (ja) | 2014-01-15 | 2017-03-23 | 株式会社新日本科学 | 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤 |
| WO2015108046A1 (ja) | 2014-01-15 | 2015-07-23 | 株式会社新日本科学 | 抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤 |
| JPWO2015108048A1 (ja) | 2014-01-15 | 2017-03-23 | 株式会社新日本科学 | 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤 |
| ES2917473T3 (es) | 2014-01-16 | 2022-07-08 | Wave Life Sciences Ltd | Diseño quiral |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1058822A (en) * | 1963-07-30 | 1967-02-15 | Ici Ltd | 3-amino-2-hydroxypropoxy heterocyclic derivatives |
| US3479358A (en) * | 1966-09-19 | 1969-11-18 | Warner Lambert Pharmaceutical | Hexahydro-9,4a - iminoethano-4a-h-xanthenes and process for their production |
| US3947456A (en) * | 1970-01-06 | 1976-03-30 | Hoffman-La Roche Inc. | Substituted 4-phenyl isoquinolines |
| US3666763A (en) * | 1970-01-06 | 1972-05-30 | Hoffmann La Roche | 4-phenyl isoquinolines and process for preparing same |
| US3878215A (en) * | 1971-12-01 | 1975-04-15 | Sandoz Ag | 2-Alkyl-3-substituted-4-aryl isoquinolines |
| US3910924A (en) * | 1972-04-13 | 1975-10-07 | Otsuka Pharma Co Ltd | 3,4-Dihydrocarbostyril derivatives and a process for preparing the same |
| US3855227A (en) * | 1972-05-08 | 1974-12-17 | C Hollander | ({31 )-di-o-isopropylidene-2-keto-l-gulonates |
| JPS5239035B2 (de) * | 1972-12-14 | 1977-10-03 | ||
| US3872125A (en) * | 1973-03-03 | 1975-03-18 | Sandoz Ag | 3-substituted-4-aryl isoquinolines |
| US3870722A (en) * | 1973-11-02 | 1975-03-11 | Sandoz Ag | 2-Methyl-3-substituted-4-aryl isoquinolines |
| AR206061A1 (es) * | 1974-11-15 | 1976-06-23 | Knoll Ag | Procedimiento para la produccion de nuevas 2-alcanoil (c1-c4)-1, 2, 3, 4-tetrahidro-8-respectivamente 7-, 6- o 5-(2-hidroxi-3-alquil (c3-c4)-aminopropoxi)-isoquinolinas de 2-alcanoil (c1-c4)-1, 2, 3, 4-tetrahidro-8-respectivamente 7- o 5-(2-hidroxi-3-alquil (c3-c4)-aminopropoxi)-6-metoxi-isoquinolinas y de 2-alcanoil (c1-c4)-1, 2, 3, 4-tetrahidro-8-respectivamente 6- o 5-(2-hidroxi-3-alquil (c3-c4)-aminopropoxi)-7-metoxi-isoquinolinas eventualmente metiladas en la posicion 1 |
-
1975
- 1975-08-09 GB GB33283/75A patent/GB1504424A/en not_active Expired
-
1976
- 1976-07-28 IE IE1668/76A patent/IE43506B1/en unknown
- 1976-07-29 NZ NZ181619A patent/NZ181619A/xx unknown
- 1976-07-29 ZA ZA764555A patent/ZA764555B/xx unknown
- 1976-07-30 IL IL50176A patent/IL50176A/xx unknown
- 1976-07-30 SE SE7608641A patent/SE7608641L/xx not_active Application Discontinuation
- 1976-07-30 BE BE169475A patent/BE844783A/xx unknown
- 1976-08-02 US US05/710,446 patent/US4113869A/en not_active Expired - Lifetime
- 1976-08-05 DE DE19762635276 patent/DE2635276A1/de not_active Withdrawn
- 1976-08-05 CH CH1002076A patent/CH622780A5/de not_active IP Right Cessation
- 1976-08-06 DK DK357976A patent/DK357976A/da not_active Application Discontinuation
- 1976-08-06 CA CA258,633A patent/CA1076119A/en not_active Expired
- 1976-08-06 AT AT586876A patent/AT354448B/de not_active IP Right Cessation
- 1976-08-06 ES ES450550A patent/ES450550A1/es not_active Expired
- 1976-08-09 JP JP51094721A patent/JPS5223083A/ja active Pending
- 1976-08-09 NL NL7608856A patent/NL7608856A/xx not_active Application Discontinuation
- 1976-08-09 HU HU76BE1265A patent/HU173560B/hu unknown
- 1976-08-09 FR FR7624258A patent/FR2320755A1/fr active Granted
- 1976-08-09 AU AU16702/76A patent/AU498422B2/en not_active Expired
-
1977
- 1977-09-01 ES ES77462062A patent/ES462062A1/es not_active Expired
- 1977-09-01 ES ES462061A patent/ES462061A1/es not_active Expired
- 1977-09-01 ES ES462058A patent/ES462058A1/es not_active Expired
- 1977-09-01 ES ES462059A patent/ES462059A1/es not_active Expired
- 1977-09-01 ES ES462060A patent/ES462060A1/es not_active Expired
-
1978
- 1978-10-05 AT AT717378A patent/AT353793B/de not_active IP Right Cessation
-
1981
- 1981-01-27 CH CH52281A patent/CH626611A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2320755B1 (de) | 1979-09-14 |
| CH622780A5 (de) | 1981-04-30 |
| ES462059A1 (es) | 1978-06-16 |
| IL50176A (en) | 1979-10-31 |
| ATA717378A (de) | 1979-05-15 |
| AT354448B (de) | 1979-01-10 |
| NZ181619A (en) | 1979-08-31 |
| AU1670276A (en) | 1978-02-16 |
| US4113869A (en) | 1978-09-12 |
| ES462061A1 (es) | 1978-06-16 |
| IL50176A0 (en) | 1976-09-30 |
| CH626611A5 (de) | 1981-11-30 |
| HU173560B (hu) | 1979-06-28 |
| ES450550A1 (es) | 1977-12-16 |
| IE43506B1 (en) | 1981-03-11 |
| ZA764555B (en) | 1977-07-27 |
| NL7608856A (nl) | 1977-02-11 |
| DE2635276A1 (de) | 1977-02-17 |
| CA1076119A (en) | 1980-04-22 |
| ES462058A1 (es) | 1978-06-16 |
| ES462062A1 (es) | 1978-06-16 |
| FR2320755A1 (fr) | 1977-03-11 |
| IE43506L (en) | 1977-02-09 |
| ATA586876A (de) | 1979-06-15 |
| GB1504424A (en) | 1978-03-22 |
| AU498422B2 (en) | 1979-03-15 |
| ES462060A1 (es) | 1978-06-16 |
| BE844783A (fr) | 1977-01-31 |
| JPS5223083A (en) | 1977-02-21 |
| SE7608641L (sv) | 1977-02-10 |
| DK357976A (da) | 1977-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT354448B (de) | Verfahren zur herstellung von neuen tetrahydro- isochinolinderivaten in form der reinen stereo- isomeren und ihrer gemische und ihren salzen | |
| AT358035B (de) | Verfahren zur herstellung von neuen indolizin- derivaten und von ihren saeureadditionssalzen | |
| AT360533B (de) | Verfahren zur herstellung von neuen trans- -hexahydropyrido-indolen und ihren saeure- additionssalzen | |
| ATA487977A (de) | Verfahren zur herstellung von neuen thieno- pyridinderivaten und ihren salzen | |
| ATA612476A (de) | Verfahren zur herstellung von neuen phenoxyal- kylcarbonsaeurederivaten und ihren salzen | |
| AT346341B (de) | Verfahren zur herstellung von neuen butyrophenonderivaten und ihren salzen | |
| ATA702976A (de) | Verfahren zur herstellung von neuen n-aryl-n- (4-piperidinyl)-arylacetamiden und ihren salzen | |
| AT349017B (de) | Verfahren zur herstellung von neuen 1-subst.-4 -aroyl-4-hydroxypiperidinen und ihren salzen | |
| AT349004B (de) | Verfahren zur herstellung von neuen 4- hydroxyindol-derivaten und ihren salzen | |
| AT359060B (de) | Verfahren zur herstellung von neuen benz-acyl- benzimidazol-2-derivaten und ihren salzen | |
| AT356110B (de) | Verfahren zur herstellung von neuen benzyliso- chinolinderivaten und ihren saeureadditions- salzen | |
| ATA602576A (de) | Verfahren zur herstellung von neuen tert- -butylaminopropoxy-indolen und ihren saeure- additionssalzen | |
| AT342034B (de) | Verfahren zur herstellung von neuen 4,4-diphenyl-2-hydroxybutylaminen und ihren salzen | |
| AT358030B (de) | Verfahren zur herstellung von neuen thiazolidinderivaten und ihren salzen | |
| AT339898B (de) | Verfahren zur herstellung von neuen, in 2-stellung substituierten 4,5-diphenylthiazolderivaten und von ihren salzen | |
| AT354427B (de) | Verfahren zur herstellung von neuen alkin- derivaten und ihren metallsalzen | |
| AT348532B (de) | Verfahren zur herstellung von neuen tricyclischen dibenzazepinderivaten und ihren salzen | |
| AT358027B (de) | Verfahren zur herstellung von neuen indol- derivaten und ihren salzen | |
| AT358046B (de) | Verfahren zur herstellung von neuen trans-5a- -aryl-decahydrobenzazepinen und ihren saeure- additionssalzen | |
| AT357535B (de) | Verfahren zur herstellung von neuen 4-amino- transdecahydrochinolinderivaten und ihren saeureadditionssalzen | |
| AT355569B (de) | Verfahren zur herstellung von neuen, substi- tuierten pyridoindolen und ihren salzen | |
| AT349005B (de) | Verfahren zur herstellung von neuen 3- nitropyrazol-derivaten und ihren salzen | |
| AT356113B (de) | Verfahren zur herstellung von neuen chinazolin- derivaten und ihren salzen | |
| ATA668277A (de) | Verfahren zur herstellung von neuen 4-hydroxy- indol-derivaten und ihren salzen | |
| ATA363080A (de) | Verfahren zur herstellung von neuen cyproheptadinderivaten und ihren salzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |